Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

News
Sodium Intake Recommendations Updated
03/06/2019
The National Academies of Sciences, Engineering and Medicine have updated their intake recommendations for sodium and potassium.
The National Academies of Sciences, Engineering and Medicine have updated their intake recommendations for sodium and potassium.
The National Academies of...
03/06/2019
Pharmacy Learning Network

Advertisement

News
Plant-Based Diets May Protect Against Mortality
03/06/2019
Findings of a recent study add to the body of evidence supporting the health benefits of plant-based diets, including reduced risks of type 2 diabetes and coronary heart disease.
Findings of a recent study add to the body of evidence supporting the health benefits of plant-based diets, including reduced risks of type 2 diabetes and coronary heart disease.
Findings of a recent study add...
03/06/2019
Pharmacy Learning Network
News
Poor Statin Adherence Increases Mortality Risk in Patients With CVD
03/06/2019
“Our findings underscore the importance of finding methods to improve adherence,” researchers wrote.
“Our findings underscore the importance of finding methods to improve adherence,” researchers wrote.
“Our findings underscore the...
03/06/2019
Pharmacy Learning Network
News
Certain Types of Antipsychotic Polypharmacy Feasible in Schizophrenia Treatment
03/06/2019
Some types of antipsychotic polypharmacy appear to be associated with fewer psychiatric rehospitalizations compared with monotherapy among adults with schizophrenia, according to a recent study.
Some types of antipsychotic polypharmacy appear to be associated with fewer psychiatric rehospitalizations compared with monotherapy among adults with schizophrenia, according to a recent study.
Some types of antipsychotic...
03/06/2019
Pharmacy Learning Network

Advertisement

News
Eye Drops Recalled
03/06/2019
A prescription antibiotic used to treat bacterial conjunctivitis is being recalled.
A prescription antibiotic used to treat bacterial conjunctivitis is being recalled.
A prescription antibiotic used...
03/06/2019
Pharmacy Learning Network
News
Review Suggests Prebiotic Benefit for Type 2 Diabetes Patients
03/06/2019
Prebiotics may have metabolic and anti-inflammatory benefits in type 2 diabetes, new research suggests.
Prebiotics may have metabolic and anti-inflammatory benefits in type 2 diabetes, new research suggests.
Prebiotics may have metabolic...
03/06/2019
Pharmacy Learning Network
News
J&J Nasal Spray Gets U.S. Approval as First New Type of Antidepressant in Decades
03/06/2019
The FDA has approved a Johnson & Johnson nasal spray antidepressant for people resistant to other treatments but placed restrictions on use of the drug, which it warned could be misused and abused.
The FDA has approved a Johnson & Johnson nasal spray antidepressant for people resistant to other treatments but placed restrictions on use of the drug, which it warned could be misused and abused.
The FDA has approved a Johnson &...
03/06/2019
Pharmacy Learning Network

Advertisement

News
U.S. FDA Chief Gottlieb Resigns
03/05/2019
Scott Gottlieb, MD, FDA commissioner, has announced plans to step down in a month.
Scott Gottlieb, MD, FDA commissioner, has announced plans to step down in a month.
Scott Gottlieb, MD, FDA...
03/05/2019
Pharmacy Learning Network
News
What Is the Appropriate Omalizumab Duration to Prevent Recurrent Hives?
03/04/2019
By evaluating the administered omalizumab injections of more than 1000 participants with chronic idiopathic urticaria, researchers sought to identify patterns in anti-inflammatory treatment.
By evaluating the administered omalizumab injections of more than 1000 participants with chronic idiopathic urticaria, researchers sought to identify patterns in anti-inflammatory treatment.
By evaluating the administered...
03/04/2019
Pharmacy Learning Network
News
CDC: 1 in 14 Women Vape During Pregnancy
03/04/2019
Overall, the prevalence of electronic vapor products use was 10.4% before pregnancy and 7% around the time of pregnancy, including 1.4% during the last 3 months of pregnancy.
Overall, the prevalence of electronic vapor products use was 10.4% before pregnancy and 7% around the time of pregnancy, including 1.4% during the last 3 months of pregnancy.
Overall, the prevalence of...
03/04/2019
Pharmacy Learning Network

Advertisement

Advertisement

Advertisement

Advertisement

Stay Informed & Sign Up Today

Pharmacy Learning Network Newsletter

Advertisement

Video Insights

Videos
David Rubin, MD, on JAK Inhibitors: Small But Mighty
11/22/2023

Featuring David Rubin, MD

Featuring David Rubin, MD
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his...
11/22/2023
Pharmacy Learning Network
Videos
Advantages and Drawbacks of Lecanemab in Alzheimer Disease Treatment
11/10/2023

Featuring Paul Schulz, MD 

Featuring Paul Schulz, MD 
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the...
11/10/2023
Pharmacy Learning Network
Videos
Immunosuppressants or Immunomodulators? Biologic Agents for Psoriasis
10/27/2023

Featuring Ronald Vender, MD, FRCPC

Featuring Ronald Vender, MD, FRCPC ...
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Application of Dupilumab to Pediatric Patients With Atopic Dermatitis
10/27/2023

Featuring Abigail Cline, MD, PhD, FAAD

Featuring Abigail Cline, MD, PhD, FAA...
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Patient Considerations When Prescribing Lecanemab for Alzheimer Disease
10/06/2023

Featuring Paul Schulz, MD

Featuring Paul Schulz, MD
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the...
10/06/2023
Pharmacy Learning Network
Headshots of Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC
Videos
Specialty Pharmacy Next: Focus on Distribution Processes, Data Utilization, New Drugs, and More
07/18/2023

Featuring Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC

Featuring Chris Fausel, PharmD, MHA, ...
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of...
07/18/2023
Pharmacy Learning Network
Videos
Leaders in Pharmacy Come Together to Discuss and Debate Oncology-Related Developments
06/28/2021
Julie Gould
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams,...
06/28/2021
Pharmacy Learning Network
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
Videos
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
04/19/2021
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief...
04/19/2021
Pharmacy Learning Network
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
Videos
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
12/28/2020
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO,...
12/28/2020
Pharmacy Learning Network
Identifying Risks of Human Error, Workarounds in Pharmacy
Videos
Identifying Risks of Human Error, Workarounds in Pharmacy
12/22/2020
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP,...
12/22/2020
Pharmacy Learning Network

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use